[ET Net News Agency, 14 April 2025] Daiwa raised the target price for Sino Biopharm
(01177) to HKD4 from HKD3.5 and maintained the "buy" rating.
The research house said it raises outer years' top-line estimates by 9-12%, driven by
the company's innovative product segment. (rc)